Literature DB >> 19653238

A prospective clinical study on early recurrence of hepatocellular carcinoma after hepatectomy.

Xin Lu1, Haitao Zhao, Huayu Yang, Yilei Mao, Xinting Sang, Ruoyu Miao, Yiyao Xu, Shunda Du, Haifeng Xu, Tianyi Chi, Zhiying Yang, Shouxian Zhong, Jiefu Huang.   

Abstract

BACKGROUND: To determine more precisely time interval from resection to recurrence of hepatocellular carcinoma (HCC) and to identify the risk factors associated with postoperative recurrence.
METHODS: From January 2004 to December 2007, 178 patients who underwent resection of HCC were followed prospectively for at least 12 months. Recurrence was identified by the digital subtraction angiography (DSA). Demographic, tumor, and disease characteristics were compared between patients with recurrence within 6 months and between 7 and 12 months, and those without recurrence to evaluate for their prognostic significance. Patients with intrahepatic recurrence were treated with trans-arterial chemoembolization (TACE) and re-assessed by CT scans, contrast-enhanced ultrasound, or MRI.
RESULTS: Recurrence developed in 52 patients between 1 and 6 months, 11 patients between 7 and 12 months, and 115 patients remained disease free for at least 1 year. The recurrence rates of 6 months and 1 year were 29.2% and 35.4%, respectively. No statistically significant difference between was observed. Fourteen (22.2%) patients with recurrence and 11 (9.6%) patients without recurrence had previously presented as multifocal HCC, and the difference is of statistical significance (P = 0.025). The diagnostic accuracy of DSA as validated by other diagnostic methods was 81.8%.
CONCLUSIONS: Recurrences are more likely to develop within the first 6 months after resection for HCC. Multifocal HCC is an important risk factor associated with early recurrence of advanced HCC after hepatectomy. DSA may serve as an important surveillance for early detection of intrahepatic recurrence after surgery.

Entities:  

Mesh:

Year:  2009        PMID: 19653238     DOI: 10.1002/jso.21354

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  19 in total

1.  Identification of miR-423 and miR-499 polymorphisms on affecting the risk of hepatocellular carcinoma in a large-scale population.

Authors:  Yanyun Ma; Rui Wang; Jun Zhang; Wenshuai Li; Chunfang Gao; Jie Liu; Jiucun Wang
Journal:  Genet Test Mol Biomarkers       Date:  2014-05-22

2.  Characteristics of Early Recurrence After Curative Liver Resection for Solitary Hepatocellular Carcinoma.

Authors:  Sung-Mi Jung; Jong Man Kim; Gyu-Seong Choi; Choon Hyuck David Kwon; Nam-Joon Yi; Kwang-Woong Lee; Kyung Suk Suh; Jae-Won Joh
Journal:  J Gastrointest Surg       Date:  2018-09-13       Impact factor: 3.452

3.  Early Recurrence of Neuroendocrine Liver Metastasis After Curative Hepatectomy: Risk Factors, Prognosis, and Treatment.

Authors:  Xu-Feng Zhang; Eliza W Beal; Jeffery Chakedis; Yi Lv; Fabio Bagante; Luca Aldrighetti; George A Poultsides; Todd W Bauer; Ryan C Fields; Shishir Kumar Maithel; Hugo P Marques; Matthew Weiss; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2017-07-20       Impact factor: 3.452

4.  Optimal duration of the early and late recurrence of hepatocellular carcinoma after hepatectomy.

Authors:  Yusuke Yamamoto; Hisashi Ikoma; Ryo Morimura; Hirotaka Konishi; Yasutoshi Murayama; Shuhei Komatsu; Atsushi Shiozaki; Yoshiaki Kuriu; Takeshi Kubota; Masayoshi Nakanishi; Daisuke Ichikawa; Hitoshi Fujiwara; Kazuma Okamoto; Chouhei Sakakura; Toshiya Ochiai; Eigo Otsuji
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

5.  TPX2 Level Correlates with Hepatocellular Carcinoma Cell Proliferation, Apoptosis, and EMT.

Authors:  Bo Liang; Chunhong Jia; Yu Huang; Hua He; Jialu Li; Hui Liao; Xiao Liu; Xincheng Liu; Xiaochun Bai; Dinghua Yang
Journal:  Dig Dis Sci       Date:  2015-05-30       Impact factor: 3.199

6.  Significance of serum connective tissue growth factor in patients with hepatocellular carcinoma and relationship with angiogenesis.

Authors:  Gui-Bo Wang; Xin-Yu Zhou; Tao Yuan; Jun Xie; Li-Ping Guo; Ning Gao; Xiao-Qin Wang
Journal:  World J Surg       Date:  2010-10       Impact factor: 3.352

7.  Hypermethylation of ACP1, BMP4, and TSPYL5 in Hepatocellular Carcinoma and Their Potential Clinical Significance.

Authors:  Xueping Qiu; Bo Hu; Yifang Huang; Yunte Deng; Xuebin Wang; Fang Zheng
Journal:  Dig Dis Sci       Date:  2015-09-19       Impact factor: 3.199

8.  Connective tissue growth factor is overexpressed in human hepatocellular carcinoma and promotes cell invasion and growth.

Authors:  Ming Xiu; Ya-Hui Liu; David R Brigstock; Fang-Hui He; Rui-Juan Zhang; Run-Ping Gao
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

9.  Glypican-3-targeted 89Zr PET imaging of hepatocellular carcinoma.

Authors:  Jonathan G Sham; Forrest M Kievit; John R Grierson; Robert S Miyaoka; Matthew M Yeh; Miqin Zhang; Raymond S Yeung; Satoshi Minoshima; James O Park
Journal:  J Nucl Med       Date:  2014-03-13       Impact factor: 10.057

10.  Pattern of disease recurrence and its implications for postoperative surveillance after curative hepatectomy for hepatocellular carcinoma: experience from a single center.

Authors:  Kit-Fai Lee; Charing C N Chong; Anthony K W Fong; Andrew K Y Fung; Hon-Ting Lok; Yue-Sun Cheung; John Wong; Paul B S Lai
Journal:  Hepatobiliary Surg Nutr       Date:  2018-10       Impact factor: 7.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.